Ignite Creation Date:
2025-12-24 @ 12:32 PM
Ignite Modification Date:
2026-04-26 @ 10:07 PM
Study NCT ID:
NCT02273661
Status:
COMPLETED
Last Update Posted:
2020-06-09
First Post:
2014-10-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of a Therapeutic Strategy Including Nebulised Liposomal Amphotericin B (Ambisome®) in Maintenance Treatment of Allergic Bronchopulmonary Aspergillosis (Cystic Fibrosis Excluded).
Sponsor:
Poitiers University Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
NEBULAMB
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None